Estimation of tritiated water formation following multiple oral doses of a tritium-labeled compound.
Wang
Y
Y
Drug Metabolism and Pharmacokinetics Department, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936, USA.
Tse
F L
FL
D000284:Administration, Oral; D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004873:Ergolines / Q000008:administration & dosage / Q000493:pharmacokinetics*; D007275:Injections, Intravenous; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D014316:Tritium; D014867:Water / Q000032:analysis*
D014150:Antipsychotic Agents; D004873:Ergolines; C110445:SDZ MAR 327; D014867:Water; D014316:Tritium